Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: A single-centre, cross-sectional study.

Hirofumi MiyakeRyuichi Minoda SadaHiroyuki AkeboYukio TsugihashiKazuhiro Hatta

Published in: Modern rheumatology (2022)

Polypharmacy and excessive polypharmacy in patients with systemic lupus erythematosus are related to medical aspects such as disease severity and comorbidities in addition to social aspects such as hospital visitation patterns and economic status.

Keyphrases

adverse drug
healthcare
risk factors
mental health
weight gain
emergency department
body mass index
electronic health record
physical activity
acute care
drug induced